These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. I. The presence of 2,5-dihydroxyphenylpyruvic acid in the urine of patients with collagen disease. NISHIMURA N; YASUI M; OKAMOTO H; KANAZAWA M; KOTAKE Y; SHIBATA Y AMA Arch Derm; 1958 Mar; 77(3):255-62. PubMed ID: 13507702 [No Abstract] [Full Text] [Related]
5. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases]. Hladíková D; Sobĕslavský C; Susta A; Havelka S Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511 [No Abstract] [Full Text] [Related]
6. Metabolism of aromatic amino acids in collagen diseases. Urinary excretion of metanephrine and normetanephrine, and spontaneous degradation of vanilpyruvic acid. Choremis KB; Agathopoulos AS; Constantsas NS; Danelatos-Athanassiadis C Clin Chim Acta; 1966 May; 13(5):574-81. PubMed ID: 5962916 [No Abstract] [Full Text] [Related]
8. [Disorders of enzymatic oxidation in diseases of the muscles]. GROS H; KIRNBERGER EJ Klin Wochenschr; 1954 Jul; 32(27-28):645-6. PubMed ID: 13193016 [No Abstract] [Full Text] [Related]
9. [Dependence of pyruvic acid excretion on volume dosage distribution in fixed field and pendulum radiotherapy]. BRUCKMOOSER M; KELLER L Strahlentherapie; 1955 Nov; 98(3):404-12. PubMed ID: 13298860 [No Abstract] [Full Text] [Related]
10. [Urinary excretion of pyruvic and alpha-ketoglutaric acids after intravenous administration of sodium pyruvate and fructose]. OHYA S Tohoku Igaku Zasshi; 1961 Jul; 64():56-67. PubMed ID: 14481434 [No Abstract] [Full Text] [Related]
11. [Urinary excretion of indole-pyroracemic acid in normal conditions and in Fölling's disease]. SCHREIER K; FLAIG H Klin Wochenschr; 1956 Nov; 34(43-44):1213. PubMed ID: 13406982 [No Abstract] [Full Text] [Related]
12. [The action of cocarboxylase in the postoperative period]. DE VITA C Rass Int Clin Ter; 1959 Dec; 39():1328-32. PubMed ID: 13815121 [No Abstract] [Full Text] [Related]
13. [Urinary corticoids in some collagen diseases and in various allergic diseases]. ROSKAM J; VAN CAUWENBERGE H Acta Med Scand Suppl; 1956; 312():337-50. PubMed ID: 13339201 [No Abstract] [Full Text] [Related]
14. [Study of mucoproteins in urine in collagen diseases, endocrine diseases and hormone therapy]. ALBEAUX-FERNET M; BUGARD P; ROMANI JD Presse Med (1893); 1955 Apr; 63(25):509-11. PubMed ID: 14384724 [No Abstract] [Full Text] [Related]
15. [Determination of urinary corticoids]. JAKOBSON T Duodecim; 1952; 68(11):972-83. PubMed ID: 13033769 [No Abstract] [Full Text] [Related]
16. [STUDY OF THE CHANGES OF AMINO ACIDS IN THE BLOOD AND URINE OF PATIENTS WITH COLLAGEN DISEASES]. GEORGESCU C; APOSTOLESCU I Stud Cercet Med Interna; 1965; 40():171-7. PubMed ID: 14338262 [No Abstract] [Full Text] [Related]
17. [Studies on acid mucopolysaccharides in the urine. II. In collagen diseases]. Kamikubo K Nihon Shonika Gakkai Zasshi; 1966 Apr; 70(4):302-8. PubMed ID: 4224598 [No Abstract] [Full Text] [Related]
18. Pyruvic aciduria in a patient with organic aciduria. LOWE CU; SMITH RT Helv Paediatr Acta; 1955 May; 10(1-2):220-3. PubMed ID: 13241959 [No Abstract] [Full Text] [Related]
19. On the isolation and characterization of substances in the urine of patients with collagen disease. Nishimura MORI Y; Matsunaka M; Matoba S; Kawasaki H; Yamaguchi M; Matsukawa S J Chronic Dis; 1967 Feb; 20(2):55-8. PubMed ID: 6020454 [No Abstract] [Full Text] [Related]
20. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease. NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226 [No Abstract] [Full Text] [Related] [Next] [New Search]